Richard E Chaisson

9PUBLICATIONS
44CO-AUTHORS
Epidemiological methodsPreventative health careMajor global burdens of diseaseRegenerative medicine (incl. stem cells)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 17, 2026
Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries.

Belén Saavedra-Cervera, Dinis Nguenha, Violet Chihota

|Feb 10, 2026
Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.

Betina Durovni, Marcelo Cordeiro-Santos, Solange Cesar Cavalcante

|Jan 06, 2026
Characterizing tuberculosis diagnosis and the associations with economic instability and employment discrimination among women living with HIV across 11 countries in sub-Saharan Africa: a cross-sectional study.

Carrie Lyons, Omar Syarif, Pim Looze

|Oct 31, 2025
Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil.

Isadora Salles, Jamile Garcia de Oliveira, Alexandra Brito de Souza

|May 13, 2025
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips

|Oct 31, 2024
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips

Pageof 2

Frequent Collaborators

2 joint publications

Radojka M Savic

2 joint publications

Valeria Saraceni

2 joint publications

Jamile Garcia de Oliveira

2 joint publications

John L Johnson